Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;25(11):992-1005.
doi: 10.1016/j.tics.2021.07.016. Epub 2021 Sep 16.

A social affective neuroscience lens on placebo analgesia

Affiliations
Review

A social affective neuroscience lens on placebo analgesia

Lauren Y Atlas. Trends Cogn Sci. 2021 Nov.

Abstract

Pain is a fundamental experience that promotes survival. In humans, pain stands at the intersection of multiple health crises: chronic pain, the opioid epidemic, and health disparities. The study of placebo analgesia highlights how social, cognitive, and affective processes can directly shape pain, and identifies potential paths for mitigating these crises. This review examines recent progress in the study of placebo analgesia through affective science. It focuses on how placebo effects are shaped by expectations, affect, and the social context surrounding treatment, and discusses neurobiological mechanisms of placebo, highlighting unanswered questions and implications for health. Collaborations between clinicians and social and affective scientists can address outstanding questions and leverage placebo to reduce pain and improve human health.

Keywords: affect; analgesia; pain; placebo; social.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The author declares no conflict of interest.

Figures

Figure 1, Key Figure:
Figure 1, Key Figure:. Expectations, affect, and social context shape pain and lead to placebo analgesia or nocebo hyperalgesia.
Laboratory models of placebo analgesia combine acute noxious stimuli (e.g. heat administered through a thermode) with experimental manipulations to measure how expectations, affect, and social factors influence perceived pain and pain-related neurobiological responses. Expectations may be driven by associative learning from cues associated with treatment or from verbal instructions about the anticipated effects of treatment. Placebos may influence affect by reducing anxiety or increasing positive emotion, whereas nocebo effects are associated with increases in anxiety. Social factors also shape placebo effects through the patient-provider interaction. Placebo analgesia refers to reduced pain as a result of expectations, affect, and the social context surrounding treatment, whereas nocebo hyperalgesia refers to the exacerbation of pain due to these psychosocial processes.
Figure 2.
Figure 2.. Brain mechanisms of placebo analgesia and relationship with salience, interoception, and nociceptive processing.
Placebo analgesia is associated with variations in brain responses to noxious stimuli that can be visualized in humans using FMRI or PET imaging. Left: The regions that are most commonly activated by painful stimuli include the anterior cingulate cortex (ACC), insula, primary and secondary somatosensory cortex (S1 and S2), and thalamus. Each of these are targeted by afferent nociceptive pathways and contain nociceptive neurons. FMRI studies that compare responses to placebo administration with a control treatment (i.e. no expected pain relief) indicate that pain-related responses in the ACC, thalamus, and anterior insula are reduced with placebo (blue), whereas placebos elicit increases in activation in modulatory regions (gold) including the dorsolateral prefrontal cortex, rostral ACC, and the opioid-rich periaqueductal gray. Upper middle: Meta-analysis of studies of placebo analgesia indicate reliable reductions in the dorsal ACC, anterior insula, and thalamus [75]. Lower middle: Despite placebo-induced reductions in pain-evoked responses in a subset of pain-related regions, placebos do not elicit reliable modulation of the Neurologic Pain Signature [30,92], which is a brain-based pattern that can reliably distinguish responses to painful and non-painful stimuli and is sensitive and specific to pain. This suggests that placebos might modulate non-specific affective and cognitive processes rather than affecting nociception. Right: Studies of placebo analgesia and other forms of pain modulation must carefully distinguish pain from salience processing (upper right) and interoception (lower right) since pain is highly salient and requires interoception, and the brain networks that process pain overlap substantially with the salience network and interoceptive processing. Maps depict term-based meta-analyses from Neurosynth [98] (red and yellow = association tests, green and purple = uniformity tests). Images of placebo-induced reductions (upper middle) were adapted with permissions from [75] and images of the Neurologic Pain Signature (lower middle) were adapted with permissions from [30].

References

    1. Volkow N et al. (2018) Use and Misuse of Opioids in Chronic Pain. Annual Review of Medicine 69, annurev-med-011817–044739 - PubMed
    1. Marshall B et al. (2019) Considerations in addressing the opioid epidemic and chronic pain within the USA. Pain Management 9, 131–138 - PubMed
    1. Kim HJ et al. (2016) Racial and ethnic differences in experimental pain sensitivity, - PubMed
    1. Burgess DJ et al. (2014) Racial differences in prescription of opioid analgesics for chronic noncancer pain in a national sample of veterans. Journal of Pain 15, 447–455 - PubMed
    1. Rahim-Williams B et al. (2012) A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter? Pain medicine (Malden, Mass.) 13, 522–540 - PMC - PubMed

Publication types